Classified as an urgent threat by the Centers for Disease Control and Prevention (CDC), Candida auris has caused much global concern. It is resistant to most first-line antifungal medications and spreads easily through direct contact as well as contact with contaminated surfaces. C. auris is predominant in patients with underlying medical issues or weakened immune systems.